Karyopharm Therapeutics (NASDAQ:KPTI) held a virtual special meeting of stockholders on Feb. 18, 2026, to vote on two proposals outlined in the company’s proxy materials. The meeting was chaired by President, CEO, and Director Richard Paulson, with Chief Legal Officer Michael Mano serving as secretary and inspector of election. Meeting format and voting procedures Paulson […]